| Eli Lilly (Suisse) SA - Abasaglar KwikPen 100 U/ml, solution injectable |
| 65069 | | 01 | | Abasaglar KwikPen 100 U/ml | | solution injectable | | A10AE04 | | Insulin Glargine | | 09.07.2015 | | |
|
| Composition |
| insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 U., glycerolum, zinci oxidum, acidum hydrochloridum dilutum, natrii hydroxidum corresp. natrium 0.04 mg, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Insulin Glargine | 3.64 mg/ml correspond Insulin Glargine 100 U/ml |
| | BAG: Active Agent | Dose |
|---|
| Insulin Glargine | 100 U |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum Dilutum | | Glycerol | | Metacresol | | Sodium Hydroxide | | Zinc Oxideate |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 5 x 3 ml | 45.30 | 68.40 | B | | No | | 002 | 5 x 3 ml | 44.37 | 64.65 | B | SL | No |
|
